An organized set of primary and secondary sources covering clinical background, drug-safety signals, and patient-safety considerations.
Prognosis and treatment of Avelumab-related Merkel Cell Carcinoma — Background & Analysis
In-depth context and analysis on this topic for researchers and advocates.
Reference: PubMed Central (PMC)
Authoritative source for clinical, regulatory, and public-health background reading.
Reference: World Health Organization (WHO)
Authoritative source for clinical, regulatory, and public-health background reading.
Reference: U.S. Food and Drug Administration (FDA)
Authoritative source for clinical, regulatory, and public-health background reading.